PA has protective effects against thrombosis, myocardial fibrosis, and cardiovascular disease by reducing p-selectin, GPIIb-IIIa, platelet activation, and by mediating the balance between thromboxane A2 and prostacyclin 2 [13,63,64]. Here, SELP is linked to Venous thrombosis.